Research Report

Testing by third-party lab accumulated 35,862 data points from 70 brands and 160 products as a benchmark for the study’s findings. Council for Responsible Nutrition criticized the study as lacking “critical context” and potentially “misleading consumers rather than empowering them.”

Cell and gene therapy sponsors are increasingly faced with hard decisions focused around mitigating potential delays.

Blending Human Experts With AI Agents Cuts Costs, Increases Access, And Improves Customer Experience

Almost 50% of biopharma are con-sidering China for clinical studies because of vast patient pools, competitive approval pathways, and cost savings.

Oncology continues to lead the way as a therapeutic focus for the pharma industry.

Sterile fill-finish is a critical process in the successful delivery of parenteral medicines.

Single-dose vials (SDVs) are a growing component of safe and effective medicines storage and administration.

Accelerated by COVID-19 restrictions, the shift to decentralized or hybrid clinical trials is expanding the scope of drug development at multiple levels.

The global pharmaceutical and biotechnology industries use a variety of gases in many ways.